King Hussein Cancer Center Executive and Leadership Team

Asem Mansour, the Chief Executive Officer at King Hussein Cancer Center, directs the overarching strategic vision for this premier oncology institution. Overseeing the integration of advanced treatment protocols, the Chief Executive Officer ensures that the facility maintains its status as a leader in cancer care across the Middle East. Mansour coordinates with the board to expand research capabilities and foster international collaborations that bring cutting-edge therapies to patients. By prioritizing operational efficiency and patient-centered care, Asem Mansour drives the organization toward achieving superior clinical outcomes. The Chief Executive Officer manages the alignment of medical departments with long-term institutional goals, ensuring that resources support the mission of providing comprehensive care for all nationalities. Through rigorous oversight of administrative and clinical functions, Mansour secures the financial and structural health of the center, ultimately reinforcing the commitment to excellence in oncology.

Nisreen Qatamish, the Director General - Chief Executive Officer at King Hussein Cancer Center, manages the institutional growth and community outreach initiatives. Focusing on the expansion of specialized oncology services, the Director General - Chief Executive Officer architects programs that enhance patient access to advanced care. Qatamish leads the development of training initiatives, ensuring that the next generation of medical professionals receives high-quality education within the facility. By fostering partnerships with global cancer centers, the Director General - Chief Executive Officer strengthens the international presence of the organization. Nisreen Qatamish monitors the impact of community programs, ensuring that the center remains a vital resource for patients of all ages. This leadership role involves balancing clinical expansion with sustainable development goals, directly influencing the quality of care provided. Through strategic planning and stakeholder engagement, Qatamish maintains the reputation of the center as a beacon of hope and innovation.

Eyad Amireh, the Chief Financial Officer at King Hussein Cancer Center, oversees the fiscal health and resource allocation for this specialized medical facility. Managing the complex budgetary requirements of a large-scale oncology center, the Chief Financial Officer ensures that capital investments support the acquisition of advanced medical technology and infrastructure. Amireh directs financial planning to sustain the extensive research and training programs that define the institution. By analyzing revenue streams and operational costs, the Chief Financial Officer optimizes the financial performance of the center, allowing for continued investment in patient care. Eyad Amireh collaborates with other executive leaders to align fiscal strategies with the broader mission of providing comprehensive cancer treatment. This role involves maintaining rigorous financial controls and transparency, which supports the long-term stability of the organization. Through prudent management, Amireh ensures that the center remains equipped to handle the evolving demands of cancer treatment.

Hikmat Abdel-Razeq, the Chief Medical Officer & Deputy Director, General at King Hussein Cancer Center, governs the clinical standards and medical operations across all departments. Overseeing the team of over 300 specialized doctors and 1,100 oncology nurses, the Chief Medical Officer & Deputy Director, General ensures that every patient receives evidence-based, high-quality care. Abdel-Razeq architects the implementation of advanced treatment protocols, focusing on improving survival rates and patient quality of life. By coordinating clinical research efforts, the Chief Medical Officer & Deputy Director, General integrates scientific discovery into daily practice, keeping the center at the forefront of oncology. Hikmat Abdel-Razeq manages the professional development of the medical staff, fostering a culture of excellence and continuous learning. This leadership role involves direct oversight of clinical outcomes and safety standards, ensuring that the center meets international benchmarks for cancer treatment and patient management.